Kewaunee Scientific Acquires Nu Aire to Enhance Laboratory Equipment Market Presence
- Kewaunee Scientific acquires Nu Aire, enhancing its laboratory and pharmacy equipment offerings and distribution network.
- This merger positions Kewaunee to better meet global laboratory market demands and serve diverse clients in life sciences.
- Kewaunee's President and CEO emphasizes the acquisition's potential for future growth and innovation in laboratory furnishings.
Kewaunee Scientific Expands Market Reach Through Nu Aire Acquisition
Kewaunee Scientific Corporation, a leading manufacturer of laboratory and technical furniture, successfully acquires Nu Aire, a Minneapolis-based company specializing in laboratory and pharmacy equipment. The acquisition, facilitated by Carl Marks Securities, marks a significant strategic move for Kewaunee, founded in 1906 and headquartered in Statesville, North Carolina. This merger not only enhances Kewaunee’s product offerings but also strengthens its distribution network, positioning the company to better address the growing demands of the global laboratory market.
The integration of Nu Aire’s product line into Kewaunee's existing portfolio promises to amplify the company’s capacity to serve a diverse range of clients in the life sciences and healthcare sectors. Chris Parisi, a Partner at Carl Marks Advisors, underscores the transformative potential of this merger, indicating that the combination will allow Kewaunee to leverage increased market reach at a time when investments in these critical fields are surging. This development is particularly timely as laboratories and healthcare facilities worldwide seek more comprehensive solutions to meet their operational needs.
Kewaunee’s President and CEO, Thomas D. Hull III, commends the role of Carl Marks Securities in aligning the strategic objectives of both companies during the acquisition process. With the backing of Carl Marks' expertise, Kewaunee aims to capitalize on the strengths of Nu Aire, a family-owned business with over 50 years of specialized experience. CFO Don Gardner highlights that this acquisition significantly enhances Kewaunee's industry position, paving the way for future growth and innovation in laboratory furnishings.
In a broader context, this acquisition illustrates the ongoing consolidation trend within the laboratory equipment industry, as companies seek to expand their capabilities and market presence amid evolving customer needs. The collaboration between Kewaunee and Nu Aire not only reinforces the legacy of both organizations but also signifies a proactive approach to addressing the challenges and opportunities within the sector.
As Kewaunee Scientific integrates Nu Aire into its operations, industry observers await the potential innovations and enhanced product offerings that may emerge from this strategic union. The acquisition is poised to set a new standard in laboratory and healthcare equipment manufacturing, reflecting the company’s commitment to excellence and adaptability in a dynamic market landscape.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

